^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG:

    IPH5201

    i
    Other names: IPH5201, IPH52, anti-huCD39 mAb, IPH-52, IPH-5201, IPH 52, IPH 5201
    Associations
    News
    Trials
    Company:
    AstraZeneca, Innate
    Drug class:
    CD39 inhibitor
    Related drugs:
    Associations
    News
    Trials